Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide

In the current investigation, we have obtained single crystals 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N-phenylhydrazine-1-carbothioamide (H2L) by refluxing 3,4 dimethoxybenzaldehyde and N(4)- methyl-N(4)-phenyl thiosemicarbazide. Here we discuss the experimental as w...

Full description

Bibliographic Details
Main Authors: K.G. Sangeetha, K.K. Aravindakshan
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Results in Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211715622002533
_version_ 1811178089842999296
author K.G. Sangeetha
K.K. Aravindakshan
author_facet K.G. Sangeetha
K.K. Aravindakshan
author_sort K.G. Sangeetha
collection DOAJ
description In the current investigation, we have obtained single crystals 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N-phenylhydrazine-1-carbothioamide (H2L) by refluxing 3,4 dimethoxybenzaldehyde and N(4)- methyl-N(4)-phenyl thiosemicarbazide. Here we discuss the experimental as well as theoretical studies of the selected molecule. Computational studies were made by Gaussian 09 program. X-ray refinement data of the molecule is used for geometry optimization process using DFT (B3LYP) method with the 6–31 + G (d,p) basis sets. The optimised molecular structure, MEP, NBO, HOMO-LUMO analysis, and NLO effects of 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N-phenylhydrazine-1-carbothioamide have been communicated in this paper. NBO analysis gave insight into the strongly delocalized structure, responsible for the nonlinearity and hence the stability of the molecule. H2L obeys Lipinski’s rule, and further in silico assessment of oral bioavailability, ADME, drug-likeness, and medicinal chemistry friendliness proposes that this molecule is a promising candidate for the cancer drug discovery process. Simultaneously, molecular docking of the compound into the 3D crystal structure of ribonucleotide reductase M−2 subunit (PDB ID: 2UW2) and Histone deacetylase 8 (PDB ID 1 T69) have been performed using GLIDE Dock Program. The study has shown that the ligand could be a potential inhibitor for the ribonucleotide reductase M−2 subunit protein.
first_indexed 2024-04-11T06:13:35Z
format Article
id doaj.art-e94e1b99e339413192aa35e4c9b44395
institution Directory Open Access Journal
issn 2211-7156
language English
last_indexed 2024-04-11T06:13:35Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Results in Chemistry
spelling doaj.art-e94e1b99e339413192aa35e4c9b443952022-12-22T04:41:09ZengElsevierResults in Chemistry2211-71562022-01-014100534Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamideK.G. Sangeetha0K.K. Aravindakshan1Department of Chemistry, The Zamorin’s Guruvayurappan College, Calicut, 673014, Kerala, India; Corresponding author.Department of Chemistry, University of Calicut, 673635 Kerala, IndiaIn the current investigation, we have obtained single crystals 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N-phenylhydrazine-1-carbothioamide (H2L) by refluxing 3,4 dimethoxybenzaldehyde and N(4)- methyl-N(4)-phenyl thiosemicarbazide. Here we discuss the experimental as well as theoretical studies of the selected molecule. Computational studies were made by Gaussian 09 program. X-ray refinement data of the molecule is used for geometry optimization process using DFT (B3LYP) method with the 6–31 + G (d,p) basis sets. The optimised molecular structure, MEP, NBO, HOMO-LUMO analysis, and NLO effects of 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N-phenylhydrazine-1-carbothioamide have been communicated in this paper. NBO analysis gave insight into the strongly delocalized structure, responsible for the nonlinearity and hence the stability of the molecule. H2L obeys Lipinski’s rule, and further in silico assessment of oral bioavailability, ADME, drug-likeness, and medicinal chemistry friendliness proposes that this molecule is a promising candidate for the cancer drug discovery process. Simultaneously, molecular docking of the compound into the 3D crystal structure of ribonucleotide reductase M−2 subunit (PDB ID: 2UW2) and Histone deacetylase 8 (PDB ID 1 T69) have been performed using GLIDE Dock Program. The study has shown that the ligand could be a potential inhibitor for the ribonucleotide reductase M−2 subunit protein.http://www.sciencedirect.com/science/article/pii/S2211715622002533Single crystal XRDNBONLOADMEMolecular DockingRibonucleotide reductase
spellingShingle K.G. Sangeetha
K.K. Aravindakshan
Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
Results in Chemistry
Single crystal XRD
NBO
NLO
ADME
Molecular Docking
Ribonucleotide reductase
title Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
title_full Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
title_fullStr Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
title_full_unstemmed Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
title_short Experimental, insilico, DFT studies of novel compound 2-{2-[(3,4-dimethoxyphenyl)methylidene]hydrazinecarbonothioyl}-N-methyl-N- phenylhydrazine-1-carbothioamide
title_sort experimental insilico dft studies of novel compound 2 2 3 4 dimethoxyphenyl methylidene hydrazinecarbonothioyl n methyl n phenylhydrazine 1 carbothioamide
topic Single crystal XRD
NBO
NLO
ADME
Molecular Docking
Ribonucleotide reductase
url http://www.sciencedirect.com/science/article/pii/S2211715622002533
work_keys_str_mv AT kgsangeetha experimentalinsilicodftstudiesofnovelcompound2234dimethoxyphenylmethylidenehydrazinecarbonothioylnmethylnphenylhydrazine1carbothioamide
AT kkaravindakshan experimentalinsilicodftstudiesofnovelcompound2234dimethoxyphenylmethylidenehydrazinecarbonothioylnmethylnphenylhydrazine1carbothioamide